The assessment guide “Drug therapy: Notes on off-label use”: an update by the Medizinischen Dienst (Medical Service)
Background: In general, the German statutory health insurance (SHI) covers the costs of medicines only if the medicines are prescribed according to the marketing authorisation (“in-label use”). However, it can be necessary to prescribe medicines for an unapproved indication or in an unapproved [for full text, please go to the a.m. URL]
Institutions
- Landesamt für Kultur und Denkmalpflege Mecklenburg-Vorpommern (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3205/24gaa12
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00